- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05374902
Efficacy of Animation, Buzzy, and Multiple Interventions on Pain in Children
March 5, 2024 updated by: Buket MERAL, Karadeniz Technical University
Efficacy of Procedural Information, Buzzy, and Multiple Interventions on Pain Management in Undergoing Venipuncture Children: A Randomised Controlled Trial
The aim of the study was to determine the effects of providing procedural informational animation, Buzzy application during the procedure, the combination of both interventions (Animated video and Buzzy), and standard care on pain management during venipuncture in children aged 6-12 years.
Study Overview
Status
Completed
Conditions
Detailed Description
A prospective randomized controlled trial design was used to determine the effects of Buzzy, procedural informational animation, multiple interventions (Buzzy and Animated video), and standard care on the pain level of 6-12 years aged children during venıpunctrue.
The study was conducted in the territory hospital pediatric blood collection unit The sample size was determined by power analysis and 45 child-parent pairs were included in each group.
The patients who met the sample selection criteria were randomly and equally assigned into 4 groups using a computer-based program.
As a data collection tools, Data Collection Form and Wong-Baker have been used.
Venipuncture-related pain was self-reported by each child, as well as through parents and nurse.
Children in the multiple interventions group were shown procedural informative animation and the venipunctıre procedure was performed with buzzy®.
Standard care was applied to the control group, in which no local anesthetic was used and families could accompany the bloodletting process.
The pain responses of the children were evaluated twice, immediately after the procedure (while the child was sitting in the blood collection chair) and 2-3 minutes after the procedure, both by the children's self-reports and by the parents and the nurse.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bayburt, Turkey
- Bayburt University/Faculty of Health Sciences
-
Ordu, Turkey
- Ordu University/Faculty of Medicine
-
Trabzon, Turkey
- Karadeniz Technical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- being between the ages of 6 and 12 years,
- admitted to the hospital as an outpatient,
- having complete skin integrity at the place where the Buzzy device will be inserted
- having the ability to verbally communicate
- parents being literate.
Exclusion Criteria:
- having any acute pain at the time of the procedure
- having any audiovisual, cognitive sensitivity, or physical disability and having a chronic or life-threatening disease
- being under the influence of any sedative/anticonvulsant/analgesic drug,
- getting blood drawn in the last month
- failure to phlebotomy at the first attempt
- having nerve damage or peripheral neuropathy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Procedural informational animation group
Children and parents have watched procedural informational animation before venipuncture.
Afterward, the children and their parents entered the blood drawn unit, and the procedure was performed as in standard care.
|
Children and parents have watched procedural informational animation before venipuncture.
Afterward, the children and their parents entered the blood drawn unit, and the procedure was performed as in standard care.
|
Experimental: Buzzy group
Buzzy® was placed on the injection site and cold application and vibration were turned on 60 s before the procedure.
Then, the nurse moved Buzzy® about 3-5 cm above the injection site.
The procedure was performed with buzzy®.
The Buzzy® intervention and phlebotomy were terminated at the same time.
|
Buzzy® was placed on the injection site and it was turned on 60 s before the procedure.
Then, the nurse moved Buzzy® about 3-5 cm above the injection site.
The procedure was performed with buzzy®.
The Buzzy® intervention and phlebotomy were terminated at the same time.
|
Experimental: Multiple interventions group
Children and parents have watched procedural informational animation before venipuncture.
Afterward, the children and their parents entered the blood drawn unit.
Buzzy® was placed on the injection site and cold application and vibration were turned on 60 s before the procedure.
Then, the nurse moved Buzzy® about 3-5 cm above the injection site.
The procedure was performed with buzzy®.
The Buzzy® intervention and phlebotomy were terminated at the same time.
|
Watching procedural informational animation video prior to venipuncture, and Buzzy application during venipuncture
|
No Intervention: Control group
Children in this group received standard care.
A local anesthetic is not used, and the parents are with their children during the procedure in the standard care of the blood collection unit
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain assessment
Time Frame: The pain was measured at 30 seconds after (immediately) the venipuncture.
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 30 seconds after (immediately) the venipuncture.
|
Pain assessment
Time Frame: The pain was measured at 2-3 minutes after the venipuncture.
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 2-3 minutes after the venipuncture.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain assessment - parent
Time Frame: The pain was measured at 30 seconds after (immediately) the venipuncture by parent
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 30 seconds after (immediately) the venipuncture by parent
|
Pain assessment - parent
Time Frame: The pain was measured at 2-3 minutes after the venipuncture by parent
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 2-3 minutes after the venipuncture by parent
|
Pain assessment - nurse
Time Frame: The pain was measured at 30 seconds after (immediately) the venipuncture by nurse.
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 30 seconds after (immediately) the venipuncture by nurse.
|
Pain assessment - nurse
Time Frame: The pain was measured at 2-3 minutes after the venipuncture by nurse.
|
Pain intensity was assessed Wong-Baker FACES Pain Rating Scale.
It is used to determine the pain level of children aged between 3 and 18 years through their facial expressions which are assigned the values of 0 and 10.
The first face represents a pain score of 0, and indicates "no hurt".
The last face represents a pain score of 10, and indicates "hurts worst."
|
The pain was measured at 2-3 minutes after the venipuncture by nurse.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2021
Primary Completion (Actual)
October 15, 2021
Study Completion (Actual)
October 15, 2021
Study Registration Dates
First Submitted
April 19, 2022
First Submitted That Met QC Criteria
May 10, 2022
First Posted (Actual)
May 16, 2022
Study Record Updates
Last Update Posted (Actual)
March 7, 2024
Last Update Submitted That Met QC Criteria
March 5, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BMERAL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
IPD Sharing Time Frame
12 months after publication
IPD Sharing Access Criteria
Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child
-
The Hospital for Sick ChildrenAga Khan University; March of DimesCompletedChild Development | Child Mortality | Child Morbidity | Child BehaviourPakistan
-
Boston Medical CenterCenter for the Study of Social PolicyCompletedChild Abuse | Parenting | Child Development | Child Rearing | Child NeglectUnited States
-
University of Southern CaliforniaSafe Water and AIDS Project (SWAP); Early Childhood Development Network for...RecruitingChild Behavior | Child Development | Language, ChildKenya
-
Windward Islands Research and Education FoundationGrand Challenges Canada; St. George's University; GRENCASECompletedDevelopment, Child | Behavior, Child | Neurocognition, ChildGrenada
-
Oral Health Centre of Expertise in Western NorwayOral Health Center of Expertise Rogaland, Norway; Childrens advocacy center... and other collaboratorsRecruitingChild Abuse | Child Neglect | Child MaltreatmentNorway
-
University of South CarolinaCompletedParents | Child Behavior | Child Health | Child, PreschoolUnited States
-
Milton S. Hershey Medical CenterRecruitingChild Abuse | Child Neglect | Child MaltreatmentUnited States
-
Boston Medical CenterValhalla Foundation; Centering Healthcare Institute; Overdeck Family foundationRecruitingParent-Child Relations | Parenting | Child Behavior | Child DevelopmentUnited States
-
South London and Maudsley NHS Foundation TrustCarol Hardy, Research Lead, South London and Maudsley NHS FoundationCompletedChild Development | Parent Child Relationships | Parent Child InteractionsUnited Kingdom
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingParent-Child Relations | Parenting | Child Behavior | Child MaltreatmentUnited States
Clinical Trials on Providing procedural informational animation video
-
University of AlbertaStollery Children's HospitalCompletedPediatric ALL | Acute Gastroenteritis | Knowledge TranslationCanada
-
Pamukkale UniversityCompletedType 1 Diabetes MellitusTurkey
-
The Alternative Sexualities Health Research AllianceRecruitingPre-Exposure ProphylaxisUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalCompletedCOVID-19 | Vaccine RefusalCanada
-
Mersin UniversityCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI); Southern Methodist University; Parkland Health...TerminatedHuman Papillomavirus VaccinesUnited States
-
University of Illinois at ChicagoNational Cancer Institute (NCI)RecruitingHigh Risk for Breast CancerUnited States
-
Zeev RosbergerCompleted
-
VA Office of Research and DevelopmentCompletedStroke | HypertensionUnited States
-
Henry Ford Health SystemUniversity of South Florida; New York UniversityEnrolling by invitationHIV SeropositivityUnited States